Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Olaparib induces tumour response as single agent in BRCA-deficient breast cancer
Dr Andrew Tutt - Breakthrough Breast Cancer Research Unit, Kings College London,...
Olaparib induces tumour response as single agent in BRCA-deficient breast cancer ( Dr Andrew Tutt - Breakthrough Breast Cancer Research Unit, Kings College London, UK )
3 Jul 2009
PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast c...
Dr Joyce O'Shaughnessy - Baylor-Charles A. Sammons Cancer Center, US
PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast cancer ( Dr Joyce O'Shaughnessy - Baylor-Charles A. Sammons Cancer Center, US )
3 Jul 2009
Therapeutic vaccine improves response rate and extends progression-free survival...
Dr Patrick Hwu - M.D. Anderson Cancer Center, US
Therapeutic vaccine improves response rate and extends progression-free survival in patients with metastatic melanoma ( Dr Patrick Hwu - M.D. Anderson Cancer Center, US )
3 Jul 2009
Bortezomib based therapies for myeloma
Dr Paul Richardson - Hematologic Oncology Dept, Dana-Farber Cancer Institute
Bortezomib based therapies for myeloma ( Dr Paul Richardson - Hematologic Oncology Dept, Dana-Farber Cancer Institute )
2 Jul 2009
Therapeutic cancer vaccine significantly prolongs disease-free survival for foll...
Dr Stephen Schuster - University of Pennsylvania School of Medicine, USA
Therapeutic cancer vaccine significantly prolongs disease-free survival for follicular lymphoma ( Dr Stephen Schuster - University of Pennsylvania School of Medicine, USA )
2 Jul 2009
PARP inhibitors show promise for hard-to-treat breast cancers
Dr. Andrew Tutt - Breakthrough Breast Cancer Research Unit, Kings College London...
PARP inhibitors show promise for hard-to-treat breast cancers ( Dr. Andrew Tutt - Breakthrough Breast Cancer Research Unit, Kings College London, UK )
25 Jun 2009
Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Dr. Jacek Gronwald, International Hereditary Cancer Centre, Poland
Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients ( Dr. Jacek Gronwald, International Hereditary Cancer Centre, Poland )
25 Jun 2009
PSA/Prostate screening
Dr. Otis W. Brawley - Chief Medical Officer, ASCO
PSA/Prostate screening ( Dr. Otis W. Brawley - Chief Medical Officer, ASCO )
25 Jun 2009
Cancer prevention strategies
Professor Peter Boyle, International Prevention Research Institute
Cancer prevention strategies ( Professor Peter Boyle, International Prevention Research Institute )
25 Jun 2009
Zoledronic acid for treament of prostate cancer
Dr. Thomas W. Leonard, Chief Scientific Officer, Merrion Pharmaceuticals
Zoledronic acid for treament of prostate cancer ( Dr. Thomas W. Leonard, Chief Scientific Officer, Merrion Pharmaceuticals )
25 Jun 2009
ASCO: Patient accrual in clinical trials
Steven K. Cheng, PhD - Oregon Health and Science University, Oregan, USA
ASCO: Patient accrual in clinical trials ( Steven K. Cheng, PhD - Oregon Health and Science University, Oregan, USA )
22 Jun 2009
ASCO: Prophylactic creams and antibiotics reduce severe drug-related skin rash
Dr. Edith Mitchell, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
ASCO: Prophylactic creams and antibiotics reduce severe drug-related skin rash ( Dr. Edith Mitchell, Thomas Jefferson University, Philadelphia, Pennsylvania, USA )
22 Jun 2009